XJTU-L453
XJTU-L453 is a PI3Kα inhibitor with an IC50 value of 0.4 nM. XJTU-L453 can inhibit the proliferation of breast cancer cell lines T47D and MCF7, with IC50 values of 0.2 μM and 0.5 μM, respectively. XJTU-L453 can inhibit the PI3K pathway, induce cell cycle arrest, and trigger cell apoptosis (apoptosis) . XJTU-L453 also has antitumor activity in MCF7 xenograft mice[1].
Product Specifications
CAS Number
[3008290-92-1]
UNSPSC
12352005
Target
Apoptosis; PI3K
Type
Reference compound
Related Pathways
Apoptosis; PI3K/Akt/mTOR
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xjtu-l453.html
Smiles
NC([C@@H](OC1=CC(OCC2=C3C=C(C4=NC=NC(NCC)=C4)C=C2)=C3C=C1)C)=O
Molecular Formula
C22H22N4O3
Molecular Weight
390.44
References & Citations
[1]Shi X, et al. Rational Design of a Novel 6H-Benzo[c]chromen Series as Selective PI3Kα Inhibitors. J Med Chem. 2024 Aug 19.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kα
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal NAC1 Antibody [Alexa Fluor 594]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
CNTROB, ID (CNTROB, LIP8, Centrobin, Centrosomal BRCA2-interacting protein, LYST-interacting protein 8) (PE) discontinued
(E) -2- (2-Aminothiazol-4-yl) -N- (2,2-diethoxyethyl) -2- (methoxyimino) acetamide